Actively Recruiting

Phase Not Applicable
Age: 18Years +
MALE
Healthy Volunteers
NCT06639932

We-INtervention Among Chinese HIV-serodiscordant Male Couples

Led by City University of Hong Kong · Updated on 2026-01-21

320

Participants Needed

4

Research Sites

95 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

HIV-serodiscordant male couples, in which one male partner is HIV-seropositive and the other is HIV-seronegative, experience multiple risks in HIV care and prevention. As stigma often hinders such couples' access to support and services, leveraging their relational resources is crucial for optimizing their outcomes. The proposed study will assess the efficacy of the three-session We-INtervention focusing on their relationship dynamics to enhance Chinese HIV-serodiscordant male couples' health and well-being. A total of 160 Chinese HIV-serodiscordant male couples (320 individuals: 160 HIV-seropositive and 160 HIV-seronegative) will be randomized at a 1:1 ratio to either the intervention or control arm. In the intervention arm, the We-INtervention will be delivered to both partners of each couple separately. In the control arm, each couple will receive health information pamphlets.

CONDITIONS

Official Title

We-INtervention Among Chinese HIV-serodiscordant Male Couples

Who Can Participate

Age: 18Years +
MALE
Healthy Volunteers

Eligibility Criteria

Eligible

You may qualify if you...

  • Both partners are male
  • Both partners are aged 18 or above
  • Both partners report being in a committed relationship for at least 3 months
  • One partner is HIV-seropositive and the other partner is HIV-seronegative (serodiscordant couple)
  • Both partners have disclosed their HIV status to each other
  • Both partners are willing to participate in this study
Not Eligible

You will not qualify if you...

  • Either partner is unable to complete the assessment due to low education level or physical or psychological constraints
  • Either partner has been diagnosed with another chronic disease such as cancer or coronary heart disease

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 4 locations

1

Fangzhouai Garden

Xiamen, Fujian, China

Actively Recruiting

2

Guangzhou Yuele Healthcare Service Center

Guangzhou, Guangdong, China

Actively Recruiting

3

Community Always There

Shenzhen, Guangdong, China

Actively Recruiting

4

Jin Tang Six-Color Rainbow Healthcare Center

Chengdu, Sichuan, China

Actively Recruiting

Loading map...

Research Team

N

Nancy Xiaonan Yu, PhD

CONTACT

J

Jianhua Hou, MS

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

SUPPORTIVE_CARE

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here